The GSK contract offers discounted pricing to committed members on pediatric and adolescent vaccines, as well as influenza vaccinations.
As of April 1, 2013, Menveo® is available through GSK, as well as the following products:
The 2013 recommended childhood and adolescent vaccine schedules have been revised.
GlaxoSmithKline (GSK) has started offering up front pricing to members who meet certain performance requirements.
Beginning March 1, 2013, GlaxoSmithKline (GSK) will accept and fulfill orders for the Menveo vaccine manufactured by Novartis.